Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

6 Apr 2009 11:56

RNS Number : 1951Q
ViaLogy PLC
06 April 2009
 



ViaLogy plc

("the Company")

Holding in Company

The Company was notified on 26 March 2009 that, as a result of an acquisition of ordinary shares in ViaLogy ("Ordinary Shares") on 24 March 2009, Barclays PLC now holds 31,190,948 Ordinary Shares (with an equivalent amount of voting rights) which represents approximately 6.19 per cent. of the issued Ordinary Share voting capital of the Company.

These shares are held indirectly by Barclays Stockbrokers Ltd and Walbrook Trustees (Jersey) Ltd.

For Further Information please contact:

ViaLogyTerry Bond, Chairman - UK & Europe +44 (0) 1235 834734 

 

Nominated Advisor (Seymour Pierce) Mark Percy +44 (0) 207 107 8000 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLCKAKPKBKDQQK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.